
Sign up to save your podcasts
Or


The world faces a peculiar problem of overuse of antibiotics, leading to drug resistance, even as some regions are unable to even access these medicines. The problem overarches human use and misuse of antibiotics, besides use in agriculture, farm animals and so. In its latest report on antimicrobial resistance (AMR), the Foundation reviews 17 global drug companies that make and supply these products and their practices.
ATM Foundation CEO, Jayasree Iyer gives us a snapshot into the work being done by drugmakers in curbing AMR, including efforts by Indian companies Aurobindo, Sun Pharma, Cipla, and Alkem in bringing in better practices in the manufacture, supply, promotion, and surveillance of these drugs.
By BusinessLineThe world faces a peculiar problem of overuse of antibiotics, leading to drug resistance, even as some regions are unable to even access these medicines. The problem overarches human use and misuse of antibiotics, besides use in agriculture, farm animals and so. In its latest report on antimicrobial resistance (AMR), the Foundation reviews 17 global drug companies that make and supply these products and their practices.
ATM Foundation CEO, Jayasree Iyer gives us a snapshot into the work being done by drugmakers in curbing AMR, including efforts by Indian companies Aurobindo, Sun Pharma, Cipla, and Alkem in bringing in better practices in the manufacture, supply, promotion, and surveillance of these drugs.

4,225 Listeners

1,713 Listeners

296 Listeners

1,649 Listeners

14 Listeners

57 Listeners

684 Listeners

2,592 Listeners

1,089 Listeners

89 Listeners

40 Listeners

5 Listeners

15 Listeners

11 Listeners

10 Listeners